Eurosurveillance | Vaccines, trust and European public health

  1. Home
  2. Eurosurveillance
  3. Volume 23, Issue 17, 26/Apr/2018
  4. Article

Editorial Open Access

http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2018.23.17.18-00210

Like 0

Access full text Article

There is no abstract available for this article.
Use the preview function to the left.

Article metrics loading...

/content/10.2807/1560-7917.ES.2018.23.17.18-00210

2018-04-26

2019-05-26

http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2018.23.17.18-00210

Full text loading...

/deliver/fulltext/eurosurveillance/23/17/eurosurv-23-17-1.html?itemId=/content/10.2807/1560-7917.ES.2018.23.17.18-00210&mimeType=html&fmt=ahah

References

  1. Rey D , Fressard L , Bocquier A , Gautier A , Peretti-Watel P , Verger P , et al. Vaccine hesitancy in the French population in 2016, and its association with vaccine uptake and perceived vaccine risk–benefit balance. Euro Surveill. 2018 ; 23 ( 17 ): 17-00816 .

  2. Musa S . Life in vaccine science – a conversation with Stanley Plotkin at the 4th Conference on Vaccines in Dubrovnik, Croatia, September 2017. Euro Surveill. 2018 ; 23 ( 17 ): 18-00147 .

  3. Mentzer D , Oberle D , Keller-Stanislawski B . Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016. Euro Surveill. 2018 ; 23 ( 17 ): 17-00468 .

  4. Lévy-Bruhl D , Desenclos J-C , Quelet S , Bourdillon F . Extension of French vaccination mandates: from the recommendation of the Steering Committee of the Citizen Consultation on Vaccination to the law. Euro Surveill. 2018 ; 23 ( 17 ): 18-00048 .

Comment has been disabled for this content

Submit comment

Close

Comment moderation successfully completed

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2018.23.17.18-00210